LianBio
NASDAQ:LIAN
0.319 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.3 | 0.297 | 0.323 | 0.316 | 0.298 | 0.199 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.3 | -0.297 | -0.323 | -0.316 | -0.298 | -0.199 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.018 | 9.454 | 10.831 | 10.577 | 8.258 | 28.591 | 12.329 | 7.653 | 4.655 | 93.03 | 53.353 | 2.712 | 116.915 |
| General & Administrative Expenses
| 17.283 | 15.59 | 15.138 | 18.668 | 16.291 | 14.551 | 16.088 | 14.383 | 8.889 | 6.461 | 7.146 | 6.492 | 2.129 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 17.283 | 15.59 | 15.138 | 18.668 | 16.291 | 14.551 | 16.088 | 14.383 | 8.889 | 6.461 | 7.146 | 6.492 | 2.129 |
| Other Expenses
| 0.141 | 0.869 | -0.044 | 8.536 | 1.253 | 0.203 | 0.417 | -0.265 | 0.003 | -0.068 | -0.124 | 0.042 | 0.099 |
| Operating Expenses
| 26.301 | 25.044 | 25.969 | 29.245 | 24.549 | 43.142 | 28.417 | 22.036 | 13.544 | 99.491 | 60.499 | 9.204 | 119.044 |
| Operating Income
| -26.301 | -25.044 | -25.969 | -29.245 | -24.549 | -43.142 | -28.417 | -22.036 | -13.544 | -99.491 | -60.499 | -9.204 | -119.044 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.141 | 0.869 | 2.362 | 10.619 | 2.658 | 0.756 | 0.697 | -0.265 | 0.003 | -0.068 | -0.124 | 0.042 | 0.099 |
| Income Before Tax
| -23.453 | -21.421 | -23.607 | -18.626 | -21.891 | -42.386 | -27.72 | -22.23 | -13.509 | -99.453 | -60.59 | -12.736 | -120.238 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.586 | 0.2 | 0.438 | -0.35 | 0.006 | 0.005 | 0.006 | -1.035 | -0.397 | 0.975 | 0.975 | 0.002 | 1.293 |
| Net Income
| -24.039 | -21.621 | -24.045 | -18.276 | -21.897 | -42.391 | -27.726 | -21.195 | -13.112 | -100.428 | -61.565 | -12.738 | -120.238 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.22 | -0.2 | -0.22 | -0.17 | -0.2 | -0.39 | -0.26 | -0.28 | -0.12 | -0.95 | -0.58 | -0.12 | -11.71 |
| EPS Diluted
| -0.22 | -0.2 | -0.22 | -0.17 | -0.2 | -0.39 | -0.26 | -0.28 | -0.12 | -0.95 | -0.58 | -0.12 | -11.71 |
| EBITDA
| -25.976 | -25.044 | -25.645 | -29.245 | -24.269 | -43.004 | -28.146 | -22.036 | -13.403 | -99.42 | -60.433 | -9.158 | -119.016 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |